Effect of change of reference standard to NHANES III on interpretation of spirometric ‘abnormality’ by Sood, Akshay et al.
International Journal of COPD 2007:2(3) 361–367
© 2007 Dove Medical Press Limited. All rights reserved
361
ORIGINAL RESEARCH
Effect of change of reference standard to NHANES 
III on interpretation of spirometric ‘abnormality’
Akshay Sood
Beth K Dawson
Joseph Q Henkle
Patricia Hopkins-Price
Clifford Qualls
Department of Medicine, University of 
New Mexico Health Sciences Center 
School of Medicine, Albuquerque, 
NM, USA (AS, CQ), and the Division 
of Pulmonary and Critical Care 
Medicine (JQH, PHP) and the Division 
of Biostatistics and Research (BKD), 
Department of Medicine, Southern 
Illinois University School of Medicine, 
Springfield, IL, USA. 62794-9636
Correspondence:  Akshay Sood
University of New Mexico Health 
Sciences Center School of Medicine
Department of Medicine
1 University of New Mexico, MSC 10 
5550 Albuquerque, NM 87131, USA
Tel + 505 272 4751
Fax + 505 272 8700
Email asood@salud.unm.edu
Abstract: The American Thoracic Society has recently recommended the use of NHANES 
III spirometric reference standard in the United States. The objective of this study was to 
better quantify the well-known ‘problem’ of the change in interpretation of spirometry, as a 
consequence of the change from the other commonly used reference standards (Morris, Kory, 
Crapo, Knudson 1976, and Knudson 1983) to NHANES III. This is a cross-sectional study of 
spirometries of 1,106 non-Hispanic Caucasian American adults, including 234 subjects with 
obstructive and 228 subjects with restrictive spirometric ‘abnormalities’. A weighted Kappa 
statistic was used to evaluate the level of agreement between NHANES III and other commonly 
used reference standards. The level of agreement in assessing the presence of an ‘abnormality’ 
was poor to moderate – values of Kappa statistic ranged from 0.13 to 0.46. There was however, 
good to very good level of agreement in assessing the severity of the ‘abnormality’ – values of 
Kappa statistic ranged from 0.61 to 0.91. This study better quantiﬁ  es the well-known differences 
in the interpretation of spirometric ‘abnormalities’ as a consequence of the recommended change 
of reference standard to NHANES III, which in turn may cause confusion among patients and 
their treating physicians.
Keywords: Reference standard, Classiﬁ  cation of severity, Obstructive spirometric abnormality’, 
Restrictive spirometric ‘abnormality’, Kappa statistic.
Introduction
Spirometry, the most frequently performed pulmonary function test (other than arterial 
blood gas study), plays an important role in diagnosing the presence and type of lung 
‘abnormality’ and classifying its severity. It plays a key role in medical surveillance 
examinations for occupational lung diseases, in determining whether to institute preventive 
or therapeutic measures, and in granting beneﬁ  ts to individuals with lung impairment. 
Observed spirometric data are compared to reference data and are expressed as percent 
predicted values, based on age, gender, height and race (American Thoracic Society 1991). 
The purpose of such a comparison is to determine ‘normality’ vs. ‘abnormality’ and in 
cases of ‘abnormality’, to determine its ‘severity’. The reference value is calculated from 
a regression equation derived from a population of ‘normal’ subjects. 
In the United States, a variety of reference standards are available for commercial 
use by pulmonary function testing laboratories. The American Thoracic Society 
and European Respiratory Society (ATS-ERS) have recently recommended the 
use of the third National Health and Nutrition Examination Survey (NHANES III) 
reference standard for the interpretation of spirometry in the United States (Pellegrino 
et al 2005). This reference standard provides ethnically appropriate equations for 
Caucasian Americans, African Americans, and Mexican Americans, thus obviating 
the need for less suitable and arbitrary race/ethnic adjustment factors (Hankinson 
et al 1999). Over time, the NHANES III reference will likely become the standard 
in most pulmonary function testing laboratories around the country.International Journal of COPD 2007:2(3) 362
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The purpose of this study was to characterize the 
well-known ‘problem’ of the changed interpretation of 
the presence and severity of a spirometric ‘abnormality’ 
in Caucasian Americans as a consequence of the change 
from other commonly used reference standards (Morris   
et al 1976; Knudson 1983) to NHANES III by pulmonary 
function testing laboratories in the United States. Although 
the concept of disagreement between the various reference 
standards is well-known (Morris et al 1971; Crapo et al 
1981; Baur et al 1999; Hankinson et al 1999; Subbarao 
et al 2004), the objective of this study was to better 
quantify these differences with respect to spirometric 
interpretation.
Methods
This is a cross-sectional study of 1,106 non-Hispanic 
Caucasian American adult subjects who were referred by 
their physicians for spirometric testing at a single pulmonary 
function laboratory at a teaching hospital in Central Illinois. 
The spirometries were performed by trained technicians, 
using standard equipment and techniques that met the 
American Thoracic Society (ATS) criteria (1987, 1995). 
This study was limited to non-Hispanic Caucasian American 
subjects to minimize the effect of race and ethnicity on 
the study results. The subjects were weighed and height 
measured, in indoor clothing without shoes, using a calibrated 
scale and stadiometer respectively. Age was recorded to the 
nearest birthday. The research using human subjects was 
conducted in accordance with the Helsinki Declaration and 
was approved by the local Institutional Review Board.
A spirometry was considered ‘abnormal’ if it met 
either of the following obstructive or restrictive criteria. 
Obstructive spirometric ‘abnormality’ was deﬁ  ned as the 
ratio of the forced expiratory volume in one second to the 
forced vital capacity (FEV1/FVC) below the lower limit of 
normal for the reference standard. Restrictive spirometric 
‘abnormality’ was deﬁ  ned as the FEV1/FVC ratio greater 
than or equal to the lower limit of normal and FVC below 
the lower limit of normal for the reference standard. The 
lower limit of normal for FEV1, FVC, and FEV1/FVC ratio 
were directly obtained from the literature for the NHANES 
III reference standard (Hankinson et al 1999). The lower 
limit of normal for the above parameters for the Morris 
(Morris et al 1971); Crapo (Crapo et al 1981), and Knudson 
(Knudson et al 1983) reference standards were calculated 
by using the following equation – Lower limit of normal 
for the parameter = Predicted value of the parameter 
−1.645*Standard error of the estimate of the parameter.
In order to further classify the severity of spirometric 
‘abnormality’, regression equations from the NHANES III 
were ﬁ  rst used, as described above, to deﬁ  ne the population 
with a spirometric ‘abnormality’ (Hankinson et al 1999). 
Subsequently, the severity of spirometric ‘abnormality’ 
was calculated in this population for each of the various 
commonly used reference standards, based upon the 
percentage predicted FEV1 values. The reference standards 
used for this part of the study included those by Morris 
(Morris 1976; Morris et al 1971, 1973); Kory (Kory et al 
1961); Crapo (Crapo et al 1981); Knudson (Knudson et al 
1976); Knudson (Knudson et al 1983); and NHANES III 
(Hankinson et al 1999). The use of percent predicted FEV1 
value in classifying severity of obstructive or restrictive 
spirometric ‘abnormality’ (as outlined in Table 1) has been 
recommended in the recent ATS/ERS guidelines (Pellegrino 
et al 2005). The use of a ‘gold standard’ reference standard 
(ie, NHANES III) in initially defining the presence of 
‘abnormality’ allowed the use of a uniform population for 
this comparison.
Statistical analysis
A weighted Kappa (κ) statistic was used to evaluate the 
level of agreement between the various reference standards 
in classifying the presence and severity of obstructive and 
restrictive spirometric ‘abnormalities’. κ is a measure of 
agreement compared to chance agreement. The κ statistic 
was interpreted using the guidelines suggested by Altman 
in Table 2 (Altman 1991). A generalized McNemar test was 
performed to evaluate for the presence of bias. A p value 
of < 0.05 was considered to be signiﬁ  cant.
Results
The 1,106 non-Hispanic Caucasian American adult subjects 
studied were mixed rural and urban residents, smokers and 
non-smokers, diseased and healthy individuals, who under-
went a spirometry for diagnostic purposes at a Midwestern 
teaching hospital. They included 706 women (63.87%) and 
400 men (36.13%), ranging in age from 18 to 91 years, with 
a mean age of 49.19 years. The body mass index ranged 
from 10.22 to 62.76 kg/m2, with a mean body mass index 
of 27.41 ± 7.04 kg/m2. The 1,106 subjects included 644 
with no ‘abnormalities’, 228 with restrictive, and 234 with 
obstructive ‘abnormalities’, as per the NHANES III reference 
values and lower limits of the normal range.
For comparing the presence of any spirometric 
‘abnormality’, the level of agreement between the other 
reference standards and NHANES III varied from poor International Journal of COPD 2007:2(3) 363
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(κ of 0.13 between Crapo and NHANES III) to moder-
ate (κ of 0.44 between Knudson 1983 and NHANES III, 
and 0.46 between Morris and NHANES III), as shown 
in Table 3. As compared to the NHANES III reference 
standard, the use of Morris et al (1983) reference standards 
was associated with an increased likelihood of interpret-
ing the presence of any ‘abnormality’ and of obstructive 
‘abnormality’ and reduced likelihood of interpreting the 
presence of a restrictive spirometric ‘abnormality’.
In order to compare the classification of severity of 
lung impairment, the study evaluated 234 subjects with 
obstructive and 228 subjects with restrictive spirometric 
‘abnormalities’, as defined by the NHANES III reference 
standard (Hankinson et al 1999). For classifying the 
severity of obstructive spirometric ‘abnormalities’, the 
level of agreement between the other reference standards 
and NHANES III varied from good (κ of 0.77 between 
Morris and NHANES III) to very good (κ of 0.91 
between Crapo and NHANES III), as shown in Table 4. 
As compared to the NHANES III reference standard, the 
‘abnormality’ was classified as less severe by the Morris 
et al (1976) reference standards (p < 0.001), usually 
less severe by the Knudson (1983) reference standards 
(although the trend for the latter was not significant, 
p = 0.06), and of similar severity by the Crapo reference 
standard (p = 0.77).
A similar approach was used for comparing the severity 
classiﬁ  cation of restrictive spirometric ‘abnormalities’ between 
the various reference standards. The level of agreement 
between the other reference standards and NHANES III for 
classifying the severity of restrictive ‘abnormality’ varied from 
good (κ of 0.61 between Morris and NHANES III) to very 
good (κ of 0.87 between Crapo and NHANES III), as shown in 
Table 5. As compared to the NHANES III reference standard, 
the ‘abnormality’ was classiﬁ  ed as less severe by the Morris et al 
(1976) reference standards (p < 0.001), usually less severe by the 
Knudson (1983) reference standard (although the trend for the 
latter was not signiﬁ  cant, p = 0.06), and of similar severity by 
the Crapo reference standard (p = 1.0). For both obstructive and 
restrictive spirometric ‘abnormalities’, the percent disagreement 
with NHANES III on severity rating was the largest when Morris 
was the original reference standard used. 
Discussion
As a US-based pulmonary function laboratory considers 
switching to the ATS/ERS-recommended NHANES 
III reference standard, it needs to be aware that the 
presence and severity of spirometric ‘abnormality’ may 
be classified differently, causing confusion in the minds 
of both the patients and their treating physicians. The 
extent of disagreement with the NHANES III-based 
interpretation will vary, depending upon the reference 
standard originally used. Particular caution must be 
exercised if the Crapo reference standard was originally 
used to classify the presence of spirometric ‘abnormality’ 
or if the Morris reference standard was originally used to 
classify the severity of spirometric ‘abnormality’ (Morris 
et al 1971). This is particularly important since Morris 
and Crapo were the two most common reference standards 
previously used in the United States, based upon a study 
in 1990 (Ghio et al 1990).
The 1991 ATS guidelines had recommended that the best 
way for each pulmonary function testing laboratory was to 
perform its own reference value study. The advantage of this 
approach was that it minimized biological variation (since the 
reference population was a sample of the population served 
by the laboratory), and analytical imprecision (since the same 
instruments, technical staff, and procedures were used for 
both the reference population and patients). However, the 
disadvantage of this approach was that it required a relatively 
large number of ‘healthy’ subjects to be tested by each 
laboratory (Pellegrino et al 2005). Unfortunately, reference 
standards in a laboratory were often chosen because they 
were available in the pulmonary function test equipment of 
the laboratory, rather than because they had been analyzed 
and found to be the best for the local population. The 2005 
Table 1 Classiﬁ  cation of severity of any spirometric ‘abnormality’, 
based upon the forced expiratory volume in one second (FEV1) 
(Pellegrino et al 2005)
Percent predicted FEV1  Degree  of  severity
70 Mild
60–69 Moderate
50–59 Moderately  severe
35–49 Severe
35 Very  severe
Table 2 Guidelines for interpreting Kappa (κ) statistic (Altman 
1991)
Kappa (κ) statistic  Level of agreement
0.81–1.00  Very good agreement
0.61–0.80 Good  agreement
0.41–0.60 Moderate  agreement
0.21–0.40 Fair  agreement
≤0.20 Poor  agreementInternational Journal of COPD 2007:2(3) 364
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ATS/ERS guidelines therefore, recognized that the previous 
recommendation (American Thoracic Society 1991) that 
each laboratory perform its own reference value study was 
impractical for most laboratories (Pellegrino et al 2005).
However, the previous recommendation (1991) also 
resulted in a variety of reference standards being used by the 
laboratories in the United States, posing a challenge for the 
geographically mobile American population (Sharma, 1995) 
and their providers. For example, a 1990 questionnaire 
survey of 139 adult respiratory disease training programs 
in the United States and Canada (Ghio et al 1990) revealed 
the use of the Morris reference standard by 47% (Morris 
Table 3 Effect of change of reference standard to NHANES III (Hankinson et al 1999) on the presence of any spirometric 
‘abnormality’ (n = 1,106, of which 644 had no ‘abnormalities’, 228 had restrictive and 234 had obstructive ‘abnormalities’ as per the 
NHANES III standard)
Reference  Percent  Weighted  Generalized  Comment on comparison with
equation  disagreement  Kappa *  McNemar’s test  NHANES III reference standard
Morris et al  33.88%  0.46 (0.41, 0.50)  p < 0.001  Morris more likely to show any 
1971        ‘abnormality’, or obstructive 
        ‘abnormality’; and less likely to 
      show  restrictive  ‘abnormality’. 
        Morris is also more likely to 
      interpret  restrictive 
        ‘abnormality’ as normal or 
      obstructive
Crapo et al   61.70%  0.13 (0.10, 0.15)  p < 0.001  Crapo more likely to show any 
1981        ‘abnormality’, or obstructive 
        ‘abnormality’; and less likely to 
      show  restrictive  ‘abnormality’. 
        Crapo is also more likely to 
      interpret  restrictive 
        ‘abnormality’ as normal or 
      obstructive
Knudson et al   35.14%  0.44 (0.40, 0.49)  p < 0.001  Knudson more likely to 
1983      show  any  ‘abnormality’,  or 
       obstructive  ‘abnormality’;  and 
        less likely to show restrictive 
        ‘abnormality’. Knudson is also 
        more likely to interpret 
       restrictive  ‘abnormality’  as 
        normal or obstructive
* Numbers in parenthesis reﬂ  ect 95% conﬁ  dence intervals
Table 4 Effect of change of reference standard to NHANES III (Hankinson et al 1999) on the classiﬁ  cation of severity of obstructive 
spirometric ‘abnormality’ (n = 234), using percent predicted FEV1
Reference  Percent  Weighted  Generalized  Comment on comparison with
equation disagreement  Kappa  *  McNemar’s test  NHANES III reference standard
Morris et al 1971  28.20  0.77 (0.72, 0.82)  p < 0.001  Morris classiﬁ  es a lower
         level of severity
Kory et al 1961   17.94  0.85 (0.81, 0.90)  p < 0.001  Kory classiﬁ  es a lower level of 
      severity
Crapo et al 1981  11.96  0.91 (0.88, 0.94)  p = 0.77  Crapo classiﬁ  es a similar level of 
      severity
Knudson et al 1976  18.80  0.85 (0.80, 0.89)  p < 0.001  Knudson usually classiﬁ  es a 
        lower level of severity
Knudson et al 1983  14.53  0.88 (0.85, 0.92)  p = 0.06  Knudson tends to classify a
        lower level of severity, although the
        trend is not statistically signiﬁ  cant
* Numbers in parenthesis reﬂ  ect 95% conﬁ  dence intervalsInternational Journal of COPD 2007:2(3) 365
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1976; Morris et al 1971, 1973), the Crapo standard by 19% 
(Crapo et al 1981), the Knudson 1983 standard by 17% 
(Knudson et al 1983), the Kory standard by 5%, (Kory 
et al 1961) and other reference standards (such as the 
Knudson 1976 standard; Knudson et al 1976) by 10% of the 
programs. Subsequently, data obtained from the NHANES 
III study, that included a random sampling of 7,429 healthy 
subjects from 81 counties across the US (Hankinson et al 
1999), was used to develop regression equations as well. 
Characteristics of these various reference standards are 
summarized in Table 6.
The 2005 ATS/ERS guidelines also recommended the use 
of the NHANES III reference standard in the United States, 
although it suggested that other standards may be used if there 
were valid reasons for that choice (Pellegrino et al 2005). The 
advantages of the NHANES III standard include the large 
size and random selection of the population studied, across 
a large age range, with nearly equal numbers of Caucasian-
Americans, African-Americans, and Mexican-Americans, 
rigorous quality control measures, and statistically sound 
coefﬁ  cients for the lower limit of normal values. Further, the 
universal use of a nation-wide equation is likely to decrease 
the inter-laboratory variability in interpreting spirometric 
values, a challenge for the geographically mobile American 
population (Sharma 1995).
Use of alternative reference standards may however, be 
valid in certain clinical settings that may currently ‘mandate’ 
the use of a speciﬁ  c standard. For instance, the Knudson 
1976 Standard (Knudson et al 1976) is currently used by 
cotton and other industries for spirometry testing done for 
medical surveillance of workers in the occupational setting 
(Occupational Safety and Health Administration 1978, 1985). 
The disagreement in classiﬁ  cation of severity of spirometric 
‘abnormality’ using NHANES III instead of the Knudson 
1976 Standard (Knudson et al 1976) in the occupational 
setting may range as high as 21.5%, as shown in Table 5. 
Similarly, the Black Lung Beneﬁ  ts Program for coal miners 
(Employment Standards Administration 2000) currently 
employs only the Knudson 1983 standards (Knudson et al 
1983) and the American Medical Guides to the Evaluation 
of Permanent Impairment (American Medical Association 
2001) currently uses only the prediction equations by Crapo et 
al (Crapo et al 1981). Although it is likely that some of these 
programs may switch to the NHANES III reference standard 
in the future, health care providers need to be mindful that its 
current use may result in signiﬁ  cant disagreements regarding 
the presence and severity of spirometric ‘abnormality’ under 
such clinical settings.
The reported disagreement between NHANES III 
and various other reference standards in interpretation of 
spirometry in this study may relate to either biological 
variation or analytical imprecision. Biological variation may 
have been introduced by the fact that the population studied 
by Morris (Morris et al 1971) were relatively unexposed to 
signiﬁ  cant urban air pollution or cigarette smoke, were at 
low altitude, and were largely volunteers from the Church 
of Jesus Christ of the Latter-day Saints (Mormon) of diverse 
northern and middle European background but possibly not 
representative of white Europeans or Americans as a whole. 
The only other population involving the Mormon religious 
sect was studied by Crapo et al (1981) but at a higher altitude 
of 1,400 ms. and in urban areas. Thus, ancestral background, 
altitude, and rural residence may contribute to biological 
variation that may potentially cause lack of agreement with 
the NHANES III reference population. Further, prediction 
equations based on cross-sectional analyses may not be 
Table 5 Effect of change of reference standard to NHANES III (Hankinson et al 1999) on the classiﬁ  cation of severity of restrictive 
spirometric ‘abnormality’, using percent predicted FVC (n = 228)
Reference   Percent   Weighted   Generalized   Comment on comparison with
equation  disagreement  Kappa  McNemar’s test  NHANES III reference standard
Morris et al 1971  32.46  0.61 (0.54, 0.69)   p < 0.001  Morris classiﬁ  es a lower level of 
       severity
Kory et al 1961  21.49  0.75 (0.69, 0.81)  p < 0.001  Kory classiﬁ  es a lower level of 
       severity
Crapo et al 1981  12.28  0.87 (0.82, 0.92)  p = 1.00  Crapo classiﬁ  es a similar level of 
       severity
Knudson et al 1976  22.37  0.74 (0.67, 0.80)  p < 0.001  Knudson usually classiﬁ  es a
        lower level of severity
Knudson et al 1983  14.49  0.84 (0.78, 0.89)  p = 0.06  Knudson tends to classify a 
        lower level of severity, although the 
        trend is not statistically signiﬁ  cant
* Numbers in parenthesis reﬂ  ect 95% conﬁ  dence intervalsInternational Journal of COPD 2007:2(3) 366
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predictive of longitudinal changes (Glindmeyer et al 1982). 
The possibility of secular trends in improving lung function 
among the US birth cohorts may be a reason why the best 
reference standards of yesterday may differ with the more 
recent NHANES III reference standard.
Further, analytical imprecision may result from a 
difference in the technique used. Morris calculated FVC 
and FEV1 using the Kory technique (Kory et al 1961) rather 
than the back extrapolation technique now recommended 
by the ATS/ERS (Miller et al 2005). The average FEV1 
calculated with the back extrapolation technique exceeds 
that calculated with the Kory technique by 179 ml (Smith 
and Gaensler 1975). This may explain why Morris classiﬁ  es 
a lower level of severity for both obstructive and restrictive 
spirometric ‘abnormalities’, when compared to the 
NHANES III reference standard. Further, Crapo et al (1981) 
showed that their study produced predicted values for FVC 
and FEV1 that were almost identical to those predicted by 
Morris et al when the data from the Morris study were 
modiﬁ  ed to be compatible with the back extrapolation 
technique recommended by the ATS/ERS (Miller et al 
2005). Crapo et al used the single curve with the largest sum 
of FVC and FEV1 and not the ATS recommended largest 
values from separate curves, if needed. This may result in a 
reduction of about 50 ml in the predicted value of FVC by 
the Crapo reference standard. Knudson et al used an older 
pneumotachograph spirometer for his reference standards 
that may have terminated the maneuver prematurely, 
resulting in lower mean FVC values (Knudson et al 1983, 
1976). The study with the highest predicted FVC and 
FEV1 values, NHANES III, had extensive quality control 
and subjects performed at least 5 FVC maneuvers – likely 
explaining the slightly larger mean FVC and FEV1 values 
(Hankinson et al 1999). Further, if a laboratory uses the 
NHANES III reference values and does not emphasize deep 
inhalations with sufﬁ  cient expiratory times, a larger number 
of their patients may falsely appear to have a restrictive 
lung disease pattern.
The strength of this study is that it better quantifies 
the differences with respect to spirometric interpretation, 
between the NHANES III and other reference standards used 
in the United States. The results of this study are therefore, 
of practical signiﬁ  cance to an American treating physician. 
This study however, has several limitations. The NHANES 
III reference standard was used to deﬁ  ne ‘abnormality’ in this 
study, instead of an extensive clinical work-up of symptoms, 
Table 6 Summary of characteristics of various reference standards
Reference   Type of Instrument  Time zero   Population  Method of
equation and date   and ability to meet  technique  characteristic  screening
of publication  ATS speciﬁ  cations     
NHANES III-1999  Dry rolling-seal  Back  Nonsmoker Caucasians,   History
Hankinson et al 1999  spirometer with a  extrapolation  African Americans, and 
  digital shaft encoder,     Mexican Americans 
 met  ATS  speciﬁ  cations     
Morris et al 1971  Stead-Wells, met  Kory   988 rural non-Hispanic  History
 ATS  speciﬁ  cations  technique  white nonsmokers,largely 
      of Mormon sect, in an area  
      <150 ms. altitude, free of  
     air  pollution 
Kory et al 1961  Collins 13.5 L metal  Kory   Hospital employees,   History, physical 
  bell, met ATS   technique  patients, medical students,   examination, chest
 speciﬁ  cations    doctors in urban locale  radiographs, and
         electrocardiogram
Crapo et al 1981  Collins 13.5 L   Back   Urban, non-Hispanic white  History, physical
  metal bell, met  extrapolation  nonsmokers, largely of  examination, and
 ATS  speciﬁ  cations    Mormon sect, at an   chest radiographs
      altitude of 1,400 ms. 
Knudson et al 1976  Pneumotachygraph,   Back  746 nonsmoker,   History
 met  ATS  speciﬁ  cations  extrapolation  non-Mexican white population,  
      without pregnant women, 
      at 730 ms. altitude 
Knudson et al 1983  Pneumotachygraph,   Back  697 nonsmoking non-  History
 met  ATS  speciﬁ  cations  extrapolation  Mexican white population International Journal of COPD 2007:2(3) 367
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pulmonary function, and radiographic testing. The study results 
depend upon the prevalence of disease in the study population, 
and will therefore change if the population studied differs in 
disease prevalence. Further, the study does not use the vital 
capacity measure instead of FVC, as is recommended by the 
2005 ATS/ERS guidelines (Pellegrino et al 2005).
Summary
The change of spirometric reference standard to NHANES III, 
as is recommended by the ATS/ERS guidelines (Pellegrino 
et al 2005), by pulmonary function testing laboratories across 
the United States, may result in varying interpretations of the 
presence and level of severity of ‘abnormality’ (Rosenfeld 
et al 2001). This difference, in turn, may result in differences 
in clinical follow-up and prognosis, different conclusions 
in longitudinal studies, and inﬂ  uence eligibility criteria for 
clinical interventions and for research studies. Particular 
caution must be exercised if the Crapo reference standard 
(Crapo et al 1981) was originally used to rate the presence of 
spirometric ‘abnormalities’ or if the Morris reference standard 
was originally used to rate its’ ‘severity’ (Morris et al 1971).
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